Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

MSF-VMDNet accurately segments skin cancer images better than existing methods.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

MK-5108 is safe and shows potential against tumors, especially alone.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Hair shaft miR-221 levels can help detect malignant melanoma.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

A new, quick method accurately detects minoxidil in drugs and cosmetics.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.